They've already said that they have enough cash to take Brachysil to market. Only in March GR said that they decided not to support the Nasdaq listing with a capital raising because they did not need the cash and they didn't want to dilute everyone's shares. It would be received very badly to do a big raising now with the share price well down since the Nasdaq listing.
There's also the sale of the orthopaedics/tissue engineering part of the business. We don't know how that's going or how much cash it will bring, but a raising now would be interpreted as a lack of interest from buyers. And that's only weeks after PureTech, which is working on the sale, was issued a heap of options.
I see no capital raising on the horizon.
Pezz
- Forums
- ASX - By Stock
- PSD
- i bet my left ball psd is planning a massive place
PSD
psivida limited
i bet my left ball psd is planning a massive place, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)